Tag: Filament Health - Page 4 - Psychedelic Alpha

Read more about the article FILAMENT HEALTH ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

FILAMENT HEALTH ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Post published:August 16, 2022
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES PARTICIPATION IN PROJECT SOLACE

FILAMENT HEALTH ANNOUNCES PARTICIPATION IN PROJECT SOLACE

Post published:July 29, 2022
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES CLOSING OF $2,500,080 PRIVATE PLACEMENT

FILAMENT HEALTH ANNOUNCES CLOSING OF $2,500,080 PRIVATE PLACEMENT

Post published:July 16, 2022
Post category:Press Release

Read more about the article FILAMENT HEALTH ISSUED THIRD PATENT BY UNITED STATES PATENT AND TRADEMARK OFFICE

FILAMENT HEALTH ISSUED THIRD PATENT BY UNITED STATES PATENT AND TRADEMARK OFFICE

Post published:July 13, 2022
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES FIRST DOSING IN GROUNDBREAKING FDA-APPROVED PSILOCIN CLINICAL TRIAL

FILAMENT HEALTH ANNOUNCES FIRST DOSING IN GROUNDBREAKING FDA-APPROVED PSILOCIN CLINICAL TRIAL

Post published:July 8, 2022
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES SIXTH PATENT ISSUANCE

FILAMENT HEALTH ANNOUNCES SIXTH PATENT ISSUANCE

Post published:July 7, 2022
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES PRIVATE PLACEMENT OF UNITS AND CONVERTIBLE DEBENTURE UNITS OF UP TO $2,500,000

FILAMENT HEALTH ANNOUNCES PRIVATE PLACEMENT OF UNITS AND CONVERTIBLE DEBENTURE UNITS OF UP TO $2,500,000

Post published:July 1, 2022
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES PATIENT DOSING THROUGH HEALTH CANADA SPECIAL ACCESS PROGRAM

FILAMENT HEALTH ANNOUNCES PATIENT DOSING THROUGH HEALTH CANADA SPECIAL ACCESS PROGRAM

Post published:June 16, 2022
Post category:Press Release

Read more about the article Filament Health and Psyence Enter into Exclusive Licensing Agreement for Natural Psilocybin Products

Filament Health and Psyence Enter into Exclusive Licensing Agreement for Natural Psilocybin Products

Post published:April 19, 2022
Post category:Press Release

Read more about the article Filament Health Is Issued Patent By United States Patent And Trademark Office

Filament Health Is Issued Patent By United States Patent And Trademark Office

Post published:April 13, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.